Why the study?
Are plasma and platelet levels of angiogenic growth factors (VEGF, Ang-1, Ang-2, Tie-2) elevated in patients with hypertension and target organ damage compared to normotensive controls?
Population
273 adults, comprising 199 patients with hypertension and 74 healthy normotensive controls.
Design
Cross-sectional
Authors
Loading...
These elevations should not alter hypertension management; hypothesis-generating for angiogenesis in target organ damage.
Are plasma and platelet levels of angiogenic growth factors (VEGF, Ang-1, Ang-2, Tie-2) elevated in patients with hypertension and target organ damage compared to normotensive controls?
Hypertensive patients, particularly those with target organ damage, exhibit elevated plasma and platelet levels of angiogenic growth factors, suggesting a role for abnormal angiogenesis and platelet activation in hypertensive target organ damage.
Nadar et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: